AstraZeneca and LVMH report earnings amid mixed global market signals

Global markets show mixed signals as AstraZeneca and LVMH prepare Q2 earnings, while Asian chip stocks rally and oil prices drop.
Global markets showed mixed signals as Asian trading moved higher, supported by gains in semiconductor shares, while oil prices experienced a drop at the start of trading. Investors turned their focus to key second-quarter earnings reports scheduled for release, led by pharmaceutical giant AstraZeneca, the largest listed company on the Stockholm Stock Exchange by market capitalization. In Europe, French luxury conglomerate LVMH is also set to publish its quarterly results following recent stock pressure. Alongside these market developments, Swedish media outlet Dagens Industri announced a condensed executive management program.
Sources: Dagens Industri.